GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME
- Written by PR Newswire Asia - News Pronto RSS
- YONDELIS® (trabectedin) now PBS listed for Australian patients
- Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas
- YONDELISÒ(trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1
SINGAPORE, July 31, 2023 /PRNewswire/ -- AUSTRALIAN cancer patients who...
Read more: GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME